The Latest Analyst Ratings for Kura Oncology
Portfolio Pulse from Benzinga Insights
Kura Oncology (NASDAQ:KURA) has received 8 analyst ratings in the last quarter, with 7 being bullish and 1 indifferent. The average price target is $26.44, indicating a significant upside from the current price of $11.45. The average price target has increased by 10.17% over the past month.
August 11, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Kura Oncology has received mostly bullish ratings from analysts, indicating a potential increase in its stock price.
The majority of the analyst ratings for Kura Oncology are bullish, with an average price target significantly higher than the current price. This suggests that the stock price may increase in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100